Loading
A phase 2 trial in colorectal cancer, run by M.D. Anderson Cancer Center, now recruiting.
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment is a phase 2, interventional study registered as NCT06617858 by M.D. Anderson Cancer Center, with a registry enrolment figure of 15 participants, started 2024-12-04 and due to reach its primary completion in 2028-02-01. Interventions recorded: AMB-05X. Conditions listed: Colorectal Cancer. Primary outcome: Safety and Adverse Events (AEs). Colorectal eligibility wording from the registry: "Histologic or pathologic confirmation of adenocarcinoma of the colon or rectum". Sites: United States. No results are recorded here; the registry entry is the source.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares MRD / molecular residual disease testing, Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.